Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytokinetics Inc (NASDAQ:CYTK)

9.49
Delayed Data
As of 4:00pm ET
 +0.08 / +0.85%
Today’s Change
5.88
Today|||52-Week Range
13.18
-9.27%
Year-to-Date
Cytokinetics (CYTK) Flagged As Strong On High Volume
Jun 28 / TheStreet.com - Paid Partner Content
Cytokinetics (CYTK) Looks Good: Stock Adds 6.8% in Session
Jun 16 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close9.41
Today’s open9.37
Day’s range9.35 - 10.13
Volume816,077
Average volume (3 months)337,932
Market cap$372.8M
Dividend yield--
Data as of 4:00pm ET, 06/30/2016

Growth & Valuation

Earnings growth (last year)-136.59%
Earnings growth (this year)-54.98%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)-38.95%
P/E ratioNM
Price/Sales14.17
Price/Book5.43

Competitors

 Today’s
change
Today’s
% change
LJPCLa Jolla Pharmaceuti...-0.62-3.73%
NUTRNutraceutical Intern...+0.78+3.49%
RIGLRigel Pharmaceutical...+0.07+3.24%
PAVMUPAVmed Inc+0.53+3.78%
Data as of 4:00pm ET, 06/30/2016

Financials

Next reporting dateJuly 27, 2016
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$28.7M
Annual profit (last year)-$37.5M
Net profit margin-130.86%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert I. Blum
Chief Financial Officer, Secretary &
Executive VP
Sharon A. Barbari
Corporate headquarters
South San Francisco, California

Forecasts

Partner Offers

Search for Jobs